SPIEGELMAN DANIEL K

MYGN

SPIEGELMAN DANIEL K serves as Director at Myriad Genetics, Inc. (MYGN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$792.3K

Net Position

Net Seller

$792.3K

Companies Traded

MYGN

Active Period

Jun 2021 – Jun 2024

5 total trades

Most Recent

Sell MYGN

Jun 4, 2024 · $167.0K

SPIEGELMAN DANIEL K's Insider Trading at Myriad Genetics, Inc. (MYGN)

Buys

0 · $0.00

Sells

5 · $792.3K

Total Shares Bought

Total Shares Sold

32,919

MYGN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 4, 2024	Sell	7,576	$22.05	$167.0K	36,705
Jun 2, 2023	Sell	8,638	$23.01	$198.8K	40,493
Jun 6, 2022	Sell	6,424	$19.25	$123.7K	33,980
Jun 17, 2021	Sell	3,139	$30.52	$95.8K	23,129
Jun 1, 2021	Sell	7,142	$28.99	$207.0K	13,420

Related Insiders

Samraat S. Raha

director, officer: President and CEO

MYGNBuy · Mar 9, 2026

S. Louise Phanstiel

director

MYGNBuy · Feb 27, 2026

Explore More Insider Trading Data

MYGN Insider Trading Activity

View all insider trades at Myriad Genetics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity